CIK 0001889109 · Large accelerated filer
BELITE BIO, INC
Sign in to watch- Ticker
- BLTE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 858-246-6240
- Business address
- 12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130
- Former names
- BELITE BIO, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $31,968,735
- in 3 filings, $32.0M under 10b5-1 plans
Net −$31,968,735. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-17 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −200 | $163.33 | $33K | 13,666 |
| 2026-04-16 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −216 | $158.28 | $34K | 15,450 |
| 2026-04-16 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −219 | $159.81 | $35K | 15,231 |
| 2026-04-16 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −201 | $160.35 | $32K | 15,030 |
| 2026-04-16 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −240 | $161.61 | $39K | 14,790 |
| 2026-04-16 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −76 | $162.26 | $12K | 14,714 |
| 2026-04-16 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −36 | $163.21 | $6K | 14,678 |
| 2026-04-16 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −12 | $164.12 | $2K | 14,666 |
| 2026-04-15 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −383 | $167.58 | $64K | 16,283 |
| 2026-04-15 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −537 | $168.64 | $91K | 15,746 |
| 2026-04-15 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −68 | $169.15 | $12K | 15,678 |
| 2026-04-15 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −8 | $170.77 | $1K | 15,670 |
| 2026-04-15 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −4 | $171.19 | $685 | 15,666 |
| 2026-04-09 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −2,500 | $180.36 | $451K | 177,634 |
| 2026-04-09 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −3,500 | $181.33 | $635K | 174,134 |
| 2026-04-09 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −3,000 | $182.40 | $547K | 171,134 |
| 2026-04-09 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −200 | $183.00 | $37K | 170,934 |
| 2026-04-09 | Chen Wan-Shan Director | Sale 10b5-1 | −1,100 | $180.43 | $198K | 9,096 |
| 2026-04-09 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −2,000 | $180.35 | $361K | 98,000 |
| 2026-04-09 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −2,000 | $181.40 | $363K | 96,000 |
Page 9 of 10 · 186 trades